# The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients

> **NCT04007276** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Tulane University** · enrollment: 60 (estimated)

## Conditions studied

- Glaucoma
- Glaucoma, Open-Angle
- Glaucoma; Drugs
- Droopy Eyelid
- Ptosis
- Glaucoma, Primary Open Angle

## Interventions

- **DRUG:** brimonidine tartrate ophthalmic solution 0.025%
- **OTHER:** sterile balanced saline solution

## Key facts

- **NCT ID:** NCT04007276
- **Lead sponsor:** Tulane University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-10
- **Primary completion:** 2031-06-01
- **Final completion:** 2036-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04007276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04007276, "The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04007276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*